Biotech Values

[dewophile]

The report could lead to the cancellation of an FDA approval given to Teva Pharmaceutical Industries Ltd. competitors Novartis' AG's Sandoz Unit and Momenta Pharmaceutical's Inc. to sell the first generic version's of the Lovenox blood thinner

where do they come up with stuff like this? the odds of that are zero. the question is will the GAO report pressure the FDA to approve TEVA and amphastar as well. in my last post i mention that if anything it is likely to delay approval of the othe rapplications for fear of lending credence to the bias concern